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Abstract
Background: The Nutrition Societies of Germany, Austria, 
and Switzerland as the joint editors of the “D-A-CH reference 
values for nutrient intake” have revised the reference values 
for vitamin B6 in summer 2019. Summary: For women, the 
average requirement (AR) for vitamin B6 intake was derived 
on the basis of balance studies using a pyridoxal-5′-
phosphate (PLP) plasma concentration of ≥30 nmol/L as a 
biomarker of an adequate vitamin B6 status. The recom-
mended intake (RI) was derived considering a coefficient of 
variation of 10%. The RIs of vitamin B6 for men, children, and 
adolescents were extrapolated from the vitamin B6 require-
ment for women considering differences in body weight, an 
allometric exponent, growth factors as appropriate, and a 
coefficient of variation. For infants aged 0 to under 4 months, 
an estimated value was set based on the vitamin B6 intake 
via breast feeding. The reference value for infants aged 4 to 
under 12 months was extrapolated from the estimated value 
for infants under 4 months of age and the average vitamin 
B6 requirement for adults. The reference values for pregnant 
and lactating women consider the requirements for the foe-
tus and the loss via breast milk. Key Messages: According to 
the combined analysis of 5 balance studies, the AR for vita-
min B6 to ensure a plasma PLP concentration of ≥30 nmol/L 
is 1.2 mg/day for adult females and the extrapolated AR for 
adult males is 1.3 mg/day. The corresponding RIs of vitamin 
B6 are 1.4 mg/day for adult females and 1.6 mg/day for adult 
males, independent of age. For infants, the estimated value 
is 0.1 mg/day and 0.3 mg/day, depending on age. The AR of 
vitamin B6 for children and adolescents ranges between 0.5 
and 1.5 mg/day, and the RI is between 0.6 mg/day and 1.6 
mg/day. During pregnancy, the AR is 1.3 mg/day in the first 
trimester and 1.5 mg/day in the second and third trimesters; 
the RI is 1.5 mg/day in the first trimester and 1.8 mg/day in 
the second and third trimesters. For lactating women, the AR 
is 1.3 mg/day and the RI is 1.6 mg/day.
© 2020 The Author(s)
Published by S. Karger AG, Basel
Introduction
Reference Values for Nutrient Intake
The D-A-CH “reference values for nutrient intake” [1] 
are jointly issued by the Nutrition Societies of Germany, 
Austria, and Switzerland (the abbreviation D-A-CH aris-
This article is licensed under the Creative Commons Attribution-
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es from the initial letters of the common country identi-
fication for the countries Germany [D], Austria [A], and 
Switzerland [CH]). Reference value is a collective term for 
recommended intake (RI), estimated values, and guiding 
values. The starting point for the derivation of reference 
values is the determination of the average requirement 
(AR). The experimentally ascertained AR assumes to 
meet the needs of the daily nutrient intake of 50% of a 
defined group of people. For the derivation of the RI, 20–
30% is added to the AR what corresponds to 2 standard 
deviations or a variation coefficient of 10–15%. Thus, a RI 
value, according to its definition, meets the requirement 
of nearly any person (approximately 98%) of sex- and 
age-stratified population groups. Estimated values are 
given when human requirements cannot be determined 
with desirable accuracy. Guiding values are given as ori-
entation [1, 2].
Reference values for nutrient intake are amounts that 
are assumed to
• protect nearly all healthy individuals in a population 
from deficiency-related conditions,
• ensure optimal physiological and psychological per-
formance, and
• create a certain body reserve [1].
The reference values should be revised regularly. Since 
2012, the D-A-CH nutrition societies have published re-
vised reference values for the intake of several nutrients 
[3–13] but not yet for vitamin B6. The last update of the 
reference values for vitamin B6 given by the D-A-CH nu-
trition societies dates to a report in 2000 [14]. In summer 
2019, the revised reference values for vitamin B6 intake 
were published in German. This paper provides a sum-
mary of this work.
Vitamin B6
Vitamin B6 is one of the water-soluble vitamins [15]. 
The term refers to a group of 2-methyl-3-hydroxy-5-hy-
droxymethyl pyridine compounds with pyridoxine activ-
ity, including pyridoxine (PN), pyridoxamine (PM), and 
pyridoxal (PL) as well as their phosphoric acid esters pyr-
idoxine 5′-phosphate (PNP), pyridoxamine 5′-phosphate 
(PMP), and pyridoxal 5′-phosphate (PLP) [16].
Physiologically, PLP and PMP function as cofactors 
for enzymes of the amino acid metabolism [16]. In addi-
tion, vitamin B6 plays a role in metabolism of carbohy-
drates [17], conversion of niacin to tryptophan [18], and 
synthesis of sphingolipids [19], 5-aminolevulinic acid (a 
precursor of haemoglobin) [20], and neurotransmitters 
[21]. Together with riboflavin, folate, and cobalamin, vi-
tamin B6 regulates homocysteine metabolism [22]. In this 
context, PLP is required for the conversion of 5,10-meth-
ylenetetrahydrofolate from tetrahydrofolate and thus for 
the remethylation of homocysteine to methionine [22]. 
Within the transsulfuration pathway, vitamin B6 is in-
volved in the degradation of homocysteine to cysteine 
[22].
The vitamin B6 content in foods was found to be af-
fected by freezing, cooking, and further processing, al-
beit the extent of the losses varied depending on the as-
sessed compound [23]. The absorption rate of vitamin B6 
depends on the diet. Vitamin B6 from animal-based foods 
has a higher bioavailability than vitamin B6 from plant-
based foods [24] due to the lower bioavailability of 
pyridoxine-5′-β-d-glucoside (PNG) found in plant-based 
foods compared to PN [24–26]. The estimated bioavail-
ability of free PN is ≥95% [27, 28], while the average bio-
availability of PNG is 50–58% [25, 26]. Depending on the 
kind of food, the PNG proportion of the total vitamin B6 
content ranges between 0 and 82% [24]. With a mixed 
diet containing 2.3 mg of vitamin B6 per day, the average 
absorption rate of vitamin B6 is 75%, based on measure-
ments of plasma PLP concentration and 24-h urinary vi-
tamin B6 excretion in men [27].
The average vitamin B6 pool in the human body is es-
timated to be ∼1,000 μmol (167 mg), whereupon up to 
80% of the vitamin B6 is located in the muscle [29, 30]. 
The majority of vitamin B6 in the muscle is found as PLP 
bound to glycogen phosphorylase [21, 29]. The vitamin 
B6 pool in muscle is relatively stable, even at a low-vita-
min B6 diet for 6 weeks [31]. In plasma, vitamin B6 exists 
primarily as PLP [32] bound to albumin [33]. In erythro-
cytes, PLP binds to haemoglobin [16]. Free PLP can be 
dephosphorylated by alkaline phosphatase to PL, which 
is capable of crossing biological membranes [16].
There is a sigmoidal relationship between vitamin B6 
intake and plasma PLP concentration [27]. Plasma PLP 
concentration reaches a new equilibrium ∼10 days after 
PN supplementation [34] or about 14 days after changing 
dietary vitamin B6 intake [27]. The half-life of vitamin B6 
is 2–6 weeks; around 2–3% of the vitamin B6 pool are lost 
per day [35]. 4-Pyridoic acid (4-PA) is the major cata-
bolic metabolite with a proportion of up to 85% of the 
total vitamin B6 excretion via urine [34].
Criteria to Assess the Supply with Vitamin B6
Vitamin B6 status can be determined directly by bio-
markers, for example, concentrations of PL, PMP, or PLP 
in plasma or erythrocytes, and total vitamin B6 or 4-PA 
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concentrations in urine [16]. Currently, plasma PLP con-
centration is considered to be the best status parameter 
[28]. It correlates with both vitamin B6 intake [36–38] and 
vitamin B6 concentration in tissue [34]. A deficient vita-
min B6 status is assumed for PLP concentrations <20 
nmol/L. PLP concentrations between 20 and 30 nmol/L 
indicate a marginal status and PLP concentrations >30 
nmol/L an adequate supply [39]. In intervention studies 
in healthy subjects who received a low-vitamin B6 diet 
(<0.5 mg vitamin B6 per day), changes in the amino acid 
profile and in the metabolism of one-carbon units and 
tryptophan occurred at PLP concentrations <30 nmol/L 
[39, 40]. It has to be considered that inflammation [41–
43], a low albumin concentration, and a high alkaline 
phosphatase activity may have a negative impact on PLP 
concentration [16]. Lifestyle factors like smoking and al-
cohol intake are considered to be influencing factors as 
well [43–45]. Current and former smokers show fre-
quently lower PLP concentrations than subjects who had 
never smoked what might be a result of oxidative stress 
caused by smoking [43]. Some studies reported a positive 
association between vitamin B6 status parameters and al-
cohol consumption [46, 47]. This observation might be 
explained by a higher vitamin B6 intake due to the con-
sumption of alcoholic beverages or changes in transsul-
furation and methylation processes [46]. In contrast, 
chronic alcohol abuse is associated with lower PLP con-
centrations [44], probably due to an impairment of liver 
function [45].
Since vitamin B6 is important for amino acid metabo-
lism, it was proposed that the requirement for vitamin B6 
is linked to protein intake [48]. However, due to incon-
sistent results, different study designs, and varying pro-
tein intake levels [48–52], no influence of protein intake 
on vitamin B6 requirements of subjects following a usual 
mixed diet is assumed.
Derivation of the Reference Values for the Intake of 
Vitamin B6
Adults
Adults under 65 Years of Age
The reference values for vitamin B6 intake in adults 
under 65 years of age were derived based on the intake 
levels that are required for a plasma PLP concentration of 
≥30 nmol/L. According to the results of intervention 
studies, daily intakes of 1.3–1.5 mg vitamin B6 are suffi-
cient to achieve a PLP concentration of ≥30 nmol/L in the 
majority of women, even at a daily protein intake of 1.2 
or 1.55 g/kg body weight reported in some of these inter-
vention trials [37, 53–55]. According to the combined 
analysis of 5 balance studies [37, 49, 53–55], the average 
vitamin B6 requirement to ensure a plasma PLP concen-
tration of ≥30 nmol/L is 1.2 mg/day, considering the 
higher bioavailability of synthetic PN [37]. Assuming a 
coefficient of variation of 10% (addition of 20%), the RI 
for women aged 19 to under 65 years is 1.4 mg/day (Ta-
ble 1).
As there are no convincing balance studies in men, 
their requirement was extrapolated from the derived re-
quirement in women. Assuming that vitamin B6 require-
ment depends on the metabolically active body mass 
[28], and taking into account an allometric exponent, the 
AR in men is 1.4 mg/day. Allometric scaling is based on 
the association between body mass and metabolism. Ac-
cording to Kleiber’s law, the metabolism scaled with a 
potency of 0.75 of body mass [56, 57]. Due to the depen-
dence of B vitamins on the metabolic body mass, an al-
lometric exponent of 0.75 is included in the calculation. 
Considering a coefficient of variation of 10% (addition of 
20%), the RI for men aged 19 to under 65 years is 1.6 mg/
day (Table 2).
Table 1. Recommended intake values for vitamin B6
Age Vitamin B6, mg/day
male female
Infantsa
0 to under 4 months 0.1
4 to under 12 months 0.3
Children and adolescents
1 to under 4 years 0.6
4 to under 7 years 0.7
7 to under 10 years 1.0
10 to under 13 years 1.2
13 to under 15 years 1.5 1.4
15 to under 19 years 1.6 1.4
Adults
19 to under 25 years 1.6 1.4
25 to under 51 years 1.6 1.4
51 to under 65 years 1.6 1.4
65 years and older 1.6 1.4
Pregnant women
1st trimester 1.5
2nd and 3rd trimesters 1.8
Lactating women 1.6
a Estimated values.
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Adults above 65 Years of Age
Several cross-sectional studies showed an inverse as-
sociation between age and PLP concentration [38, 51, 58–
61]; others, however, did not [32, 62, 63]. In a long-term 
study including 360 subjects ≥60 years of age, no decrease 
of the PLP concentration with advancing age was ob-
served [52]. Possible causes discussed for lower PLP con-
centrations in elderly people comprise lower vitamin B6 
intake, reduced albumin synthesis, inflammation, and in-
creased alkaline phosphatase activity [16, 36, 62]. How-
ever, age-related changes of vitamin B6 bioavailability or 
metabolism have not been proven so far [36, 62]. In a 
study including 12 subjects aged >60 years, the vitamin B6 
intake level was estimated that was required at different 
protein intakes to regain the baseline plasma PLP concen-
tration after a low-vitamin B6 diet [50]. In 2 women and 
1 man who had a daily protein intake of 0.8 g/kg body 
weight, this required a vitamin B6 intake of 1.33 mg/day 
(women) and 1.36 mg/day (men), respectively. Due to the 
small sample size and the fact that baseline PLP concen-
trations exceeded 30 nmol/L [50], the RI for adults above 
65 years of age is 1.4 mg/day for women and 1.6 mg/day 
for men (Table 1) and thus corresponds to the reference 
values of younger adults.
Children and Adolescents
No data from balance studies are available regarding 
the vitamin B6 requirement for children and adolescents. 
Therefore, the reference values for children and adoles-
cents are based on the values compiled for adults and take 
into account differences in body weight, an allometric ex-
ponent, growth factors to consider the requirements for 
growth, and a coefficient of variation of 10% (addition of 
20%) (Table 3). Growth factors at the different age groups 
were calculated from the protein requirement for growth 
in relation to the maintenance requirement according to 
the World Health Organization (WHO) [14, 64]. When 
using the age groups and reference body weights the D-
A-CH reference values are based upon [1], the AR values 
range between 0.5 and 1.5 mg/day. The resulting RI val-
ues for vitamin B6 range from 0.6 mg/day (for 1 to under 
4-year-olds) to 1.4 mg/day for female adolescents and 1.6 
mg/day for male adolescents (15 to under 19-year-olds) 
(Tables 1, 3). We want to point out that the calculated 
values for adolescents aged 15 to under 19 years are high-
er than those for adults (Table 3). However, as no evi-
dence of a higher vitamin B6 requirement for adolescents 
exists, the RI values for female and male adolescents aged 
15 to under 19 years are assumed to be the same as for 
adults (Table 3).
Infants
The reference values for the intake of vitamin B6 for 
infants aged 0 to under 4 months were derived based on 
the vitamin B6 content of breast milk, which is considered 
to be the optimal diet for infants [65, 66]. The reference 
values for infants are therefore estimated values.
The average vitamin B6 content from 2 studies of ma-
ture milk from lactating women not supplementing vita-
min B6 is 0.145 mg/L [67, 68]. Assuming an average breast 
milk intake of 750 mL/day [69], vitamin B6 intake in an 
exclusively breastfed infant is approximately 0.109 mg vi-
Table 2. Derivation of the average requirement and recommended intake values for vitamin B6 for men ≥19 years of age considering 
differences in average body weight and an allometric exponent






Average vitamin B6 requirement 
considering reference body weight 
and allometric exponent, mg/dayb
Coefficient of variation 
10% (addition of 20%), 
mg/day
Recommended intake 
for vitamin B6 
(rounded), mg/day
19 to under 25 years 70.8 60.5 1.35 1.62 1.6
25 to under 51 years 70.7 60.0 1.36 1.63
51 to under 65 years 68.7 58.2 1.36 1.63
65 years and older 66.8 57.1 1.35 1.62
a Reference values for body weight are calculated from the median body height determined in the German Health Interview and 
Examination Survey for Adults (DEGS1) corresponding to a BMI of 22 kg/m2 [1]. Based on data of DEGS1, the median body heights were 
179.4, 179.2, 176.7, and 174.2 cm for male subjects in the age groups 18–29, 30–39, 50–59, and 60–69 years, respectively [97]. For female 
subjects, the median body heights were 165.8, 165.1, 162.6, and 161.1 cm in the respective age groups [97]. These median values were 
used for the appropriate age groups mentioned in this table, albeit the age classification is not entirely homogeneous. b Calculated from: 
average requirementwomen [mg/day] × (reference body weightmen [kg]/reference body weightwomen [kg])allometric exponent [28]; average 
requirementwomen: 1.2 mg/day; allometric exponent: 0.75.
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tamin B6/day. This intake is sufficient to ensure a PLP 
concentration of ≥30 nmol/L [68]. Therefore, the esti-
mated value for adequate vitamin B6 intake is 0.1 mg/day 
for infants aged 0 to under 4 months.
For infants aged 4 to under 12 months, data on the av-
erage vitamin B6 requirement are lacking. Thus, in line 
with the approach of the European Food Safety Author-
ity (EFSA) [28], the vitamin B6 reference value for infants 
of this age group is derived by averaging the results of the 
extrapolation from the estimated value for infants under 
4 months of age and of the extrapolation from the AR for 
adults. Based on the estimated value for infants under 4 
months of age (0.1 mg/day), considering differences in 
body weight [1] and the allometric exponent, the vitamin 
B6 intake is 0.14 mg/day. However, based on the average 
vitamin B6 requirement for adults (1.2 mg/day for women 
and 1.4 mg/day for men), considering differences in body 
weight, the allometric exponent, and the growth factor 
[1], the vitamin B6 intake is 0.45 mg/day for female in-
fants and 0.49 mg/day for male infants. By calculating the 
arithmetic mean, an estimated value for an adequate vi-
tamin B6 intake of 0.3 mg/day is derived (Table 4).
Pregnancy
Plasma PLP concentration decreases during pregnan-
cy; especially in the third trimester, concentrations <20 
nmol/L were observed [70–72]. Possible reasons are hae-
modilution, enhanced PLP transfer to the foetus, in-
creased alkaline phosphatase activity, and a higher re-
quirement due to tissue growth [72, 73]. In line with the 
EFSA [28], the requirement during pregnancy is derived 
on the basis of body weight gain and average tissue con-
tent of vitamin B6. Based on weight gain during pregnan-
cy (16.7 g/day in the first, 60.6 g/day in the second, and 
54.2 g/day in the third trimester [1]), a vitamin B6 require-
ment of 15 nmol/g tissue growth (3.7 mg/kg) [30] and an 
average bioavailability of 75%, the AR is 1.3 mg/day in the 
first trimester and 1.5 mg/day in the second and third tri-
mesters. After taking a coefficient of variation of 10% (ad-
dition of 20%) into account, the recommended vitamin 
Table 3. Derivation of the average requirement and recommended intake values for vitamin B6 for children and adolescents considering 
differences in average body weight, an allometric exponent, and growth factors





Average vitamin B6 
requirement considering 
reference body weight, 




(addition of 20%), 
mg/day
Recommended 
intake for vitamin 
B6 (rounded), 
mg/day
1 to under 4 years Male 13.9 0.25 0.52 0.62 0.6Female 13.2 0.25 0.48 0.58
4 to under 7 years Male 20.2 0.06 0.58 0.70 0.7Female 20.1 0.06 0.56 0.67
7 to under 10 years Male 29.3 0.13 0.82 0.98 1.0Female 28.7 0.13 0.78 0.94
10 to under 13 years Male 41.0 0.13 1.05 1.26 1.2Female 42.1 0.11 1.02 1.23
13 to under 15 years Male 55.5 0.10 1.28 1.54 1.5
Female 54.0 0.07 1.19 1.42 1.4
15 to under 19 years Male 69.2 0.07 1.47 1.77 1.6d
Female 59.5 0.02 1.22 1.46 1.4d
a Reference values for body weight correspond to the median body weight determined in the German Health Interview and Examination 
Survey for Children and Adolescents in Germany (KiGGS; 2003–2006) [98]. In each case, the values reflect the midpoint of the respective 
age range. b Growth factors at the different ages were calculated as the proportional increase in protein requirement for growth relative 
to the maintenance requirement according to the WHO [14, 64]. c Calculated from: average requirementadults [mg/day] × (reference body 
weightchildren/adolescents [kg]/reference body weightadults [kg])allometric exponent × (1 + growth factorchildren/adolescents) [28]; average 
requirementadults: male 1.4 mg/day, female 1.2 mg/day; reference body weightadults (age group 25 to under 51 years): men 70.7 kg, women 
60.0 kg [1]; allometric exponent: 0.75. d For adolescents aged 15 to under 19 years, the reference value is assumed to be the same as for 
adults (see Table 1), as there is no evidence of a higher requirement.
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B6 intake for pregnant women is 1.5 mg/day in the first 
trimester and 1.8 mg/day in the second and third trimes-
ters.
Lactation
Vitamin B6 concentration of breast milk is influenced 
by the mother’s diet [67]. Based on a vitamin B6 secretion 
with breast milk of 0.1 mg/day (see the section Infants), 
an average bioavailability of 75% and an average breast 
milk intake of 750 mL/day of an exclusively breastfed in-
fant, the AR in lactating women is 1.3 mg/day. Consider-
ing a coefficient of variation of 10% (addition of 20%), the 
recommended vitamin B6 intake is 1.6 mg/day.
Preventive Aspects
In the following, the available data on health-related 
aspects of vitamin B6 are outlined without an evidence 
judgement. As most studies do not investigate vitamin B6 
alone but in combination with other B vitamins, it is 
sometimes not possible to evaluate the unique role of the 
different B vitamins.
Several epidemiological long-term studies repeatedly 
demonstrated inverse associations between vitamin B6 
status or vitamin B6 intake and risk of depression [74], 
cardiovascular diseases [75], and cognitive impairment 
[76, 77]. Furthermore, an inverse association between vi-
tamin B6 status and inflammation has been described [41, 
43, 78]. Meta-analyses of epidemiological studies indicate 
negative associations for both dietary vitamin B6 intake 
and PLP concentration with the general risk of cancer and 
specifically the risk of cancers of the gastrointestinal tract 
such as the colorectum [79, 80], oesophagus, stomach, 
and pancreas [80]. Another meta-analysis indicates a 
negative association between the PLP concentration and 
the risk of breast cancer in postmenopausal women [81]. 
However, an association between vitamin B6 intake and 
risk of breast cancer could not be proven [81].
So far, most intervention studies could not confirm 
preventive effects of vitamin B6 regarding risk of cancer, 
depression, cardiovascular diseases, impairment of cog-
nitive functions in older age or Alzheimer’s disease, or an 
effect on bone remodelling [80, 82–89]. Based on avail-
able data, a vitamin B6 intake exceeding the reference val-
ues is not clearly associated with preventive effects on 
health in the general population.
Discussion and Conclusion
Within the present revision of the D-A-CH reference 
values for the intake of vitamin B6, the method of deriva-
tion has been changed: it is now based on balance studies 
using plasma PLP concentration as a biomarker to deter-
mine the AR. Reliable data on the vitamin B6 intake levels 
that are sufficient to achieve the desirable plasma PLP 
concentration of 30 nmol/L are available for women, but 
not for children, adolescents, and men. Therefore, the ref-
erence values for children and adolescents were derived 
from the data for women considering differences in body 
weight and increased requirements in children and ado-
Table 4. Derivation of the estimated value for the intake of vitamin B6 for infants aged 4 to under 12 months
Age Sex Reference 
body weight,a 
kg [1]
Derivation based on the 
estimated value for infants 
under 4 months of age: vitamin 
B6 intake considering reference 
body weight and allometric 
exponent,b mg/day
Derivation based on the average 
vitamin B6 requirement for 
adults: vitamin B6 intake 
considering reference body 














4 to under 12 
months
Male 8.6 0.14 0.49 0.31
0.3
Female 7.9 0.14 0.45 0.29
a Reference values for body weight correspond to the median body weight of the WHO child growth standards [99] for the age of 8 
months. b Calculated from: estimated value0–4 months [mg/day] × (reference body weight4–12 months [kg]/reference body weight0–4 months 
[kg])allometric exponent according to [28]; estimated value0–4 months: 0.1 mg/day (see Table 1); reference body weight0–4 months: male 5.6 kg, 
female 5.1 kg [1]; allometric exponent: 0.75. c  Calculated from: average vitamin B6 requirementadults [mg/day] × (reference body 
weight4–12 months [kg]/reference body weightadults [kg])allometric exponent × (1 + growth factor0–4 months) according to [28]; average vitamin B6 
requirementadults: male 1.4 mg/day, female 1.2 mg/day; reference body weightadults (age group 25 to under 51 years): male 70.7 kg, female 
60.0 kg [1]; allometric exponent: 0.75; growth factor4–12 months: 0.7 [1].
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lescents due to growth. Likewise, the reference values for 
men were derived based on the AR of women with con-
sideration of differences in body weight. Due to the 
changed derivation, the reference values for some age 
groups are slightly higher than before. For pregnancy and 
lactation, the reference values are somewhat lower. How-
ever, higher intake levels for pregnant women compared 
to non-pregnant women are now recommended already 
in the first trimester, whereas previously higher intake 
levels were recommended from the beginning of the sec-
ond trimester.
The derivation and magnitude of the revised reference 
values show similarities as well as differences to the deri-
vation and magnitude of reference values set by the EFSA 
[28], Institute of Medicine (IOM) [90], and WHO [91]. 
For infants, the D-A-CH reference values for vitamin B6 
are in line with the reference values set by EFSA, IOM, 
and WHO, whereas for other age categories as well as for 
pregnant and lactating women, differences can be noted.
Similarities regarding the derivation include (1) the 
absence of connecting the vitamin B6 requirements to the 
protein intake levels, (2) the use of the circulating PLP 
concentration as a biomarker for vitamin B6 status, (3) the 
extrapolation of the ARs for children, adolescents, and 
pregnant/lactating women from the ARs of adults, (4) the 
vitamin B6 content in human milk as a basis for deriving 
reference values for infants, (5) the higher AR for preg-
nancy and lactation due to foetus requirements and milk 
secretion, respectively, and (6) the nature of the reference 
values, that is, adequate intake and estimated values for 
infants and RIs for adolescents and adults.
The differences include, for instance, (1) cut-off values 
for defining adequate PLP concentrations, (2) age catego-
ries, reference body weights, and growth factors, (3) age 
at which sex-specific reference values were applied, (4) 
requirements of older adults, and (5) reference values de-
pending on trimester. More precisely, IOM [90] and 
WHO [91] use a PLP concentration of ≥20 nmol/L to de-
fine an adequate vitamin B6 status and also consider stud-
ies analyzing other vitamin B6 biomarkers, such as activa-
tion coefficients of erythrocyte aspartate aminotransfer-
ase and erythrocyte alanine aminotransferase as well as 
homocysteine concentration and the renal excretion of 
tryptophan metabolites following a tryptophan loading 
test to derive ARs for adults, respectively. In contrast, 
EFSA bases the derivation of ARs on the achievement of 
a PLP concentration of ≥30 nmol/L [28] similar to the 
here presented derivation. With respect to the age groups, 
the D-A-CH reference values for children and adoles-
cents are stratified into 7 age groups, whereas IOM [90] 
and WHO [91] use only 4 and EFSA [28] applies 5 age 
groups. This and the fact that different population studies 
were quoted as source of the reference body weights and 
growth factors explain why the age at which sex-specific 
reference values were set differs among the authorities. 
With reference to the above-mentioned study by Ribaya-
Mercado et al. [50], IOM [90] and WHO [91] assume that 
older subjects require a higher vitamin B6 intake to main-
tain a sufficient vitamin B6 state compared to young 
adults and thus set age-specific reference values for adults. 
EFSA [28] abstains from setting age-specific reference 
values in adulthood but takes the results from Ribaya-
Mercado et al. [50] into account by applying an AR of 1.3 
mg/day for women and, after extrapolation, 1.5 mg/day 
for men. In contrast, D-A-CH nutrition societies con-
clude that the evidence is insufficient to set a higher AR 
and in consequence RI for older adults. In terms of preg-
nancy, the here presented D-A-CH reference values for 
pregnant women are the only ones that imply a trimester-
specific vitamin B6 intake, although EFSA [28], IOM [90], 
and WHO [91] acknowledge that the lower vitamin B6 
state is particularly evident in late gestation. In contrast 
to EFSA [28], IOM [90], and WHO [91], the D-A-CH 
reference values are based on trimester-specific weight 
gain during pregnancy taking into account that vitamin 
B6 requirements rely on tissue growth.
According to representative data from the German Na-
tional Nutrition Survey II, the median vitamin B6 intake 
is 1.2 mg/day in women and 1.6 mg/day in men [92, 93]. 
This means that the recommended vitamin B6 intake of 
1.4 mg/day for women and 1.6 mg/day for men is not 
achieved by parts of the general adult population in Ger-
many. Using the PRIs set by EFSA [28], that is, 1.6 mg/day 
for women and 1.7 mg/day for men, the situation appears 
even more critical, particularly for female subjects. How-
ever, irrespectively of the applied reference value, a vita-
min B6 intake below the RI does not necessarily represent 
a state of vitamin B6 deficiency; rather it indicates a high-
er risk of suboptimal intake. The aim of reference values 
is the adequate nutrient supply of the healthy individuals 
in a population. The RI meets the requirements of ∼98% 
of the population. Thus, the RI exceeds the actual require-
ments of most people. Therefore, the RI is not suitable to 
distinguish between an adequate and inadequate nutrient 
intake on individual level or to diagnose a state of nutrient 
deficiency. For the examination of the probability that the 
usual intake of an individual is inadequate or to estimate 
the prevalence of inadequate intake in groups, the AR can 
be used [94, 95]. Referring to the AR, the above-men-
tioned median vitamin B6 intake levels found in the Ger-
Jungert et al.Ann Nutr Metab 2020;76:213–222220
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man National Nutrition Survey II are in line with the AR 
for women and exceeded the AR for men. In light of this 
and the fact that the nutrient data base used to calculate 
the vitamin B6 intake levels in the German National Nutri-
tion Survey II considered predominantly non-fortified 
foods, vitamin B6 is apparently no critical nutrient for the 
general population. However, the diagnosis of a deficiency 
should base on a comprehensive individual assessment in-
cluding the measurement of recognized biomarkers, such 
as plasma PLP concentration for vitamin B6.
Several protein-rich foods are good vitamin B6 sources 
[16]. High levels of vitamin B6 can be found in fish, such 
as sardines (cooked: 0.92 mg/100 g) and mackerels 
(cooked: 0.59 mg/100 g), as well as meat products, such as 
beef liver (cooked: 0.91 mg/100 g) [96]. In addition, cere-
als (e.g., whole-wheat flour: 0.46 mg/100 g), nuts (e.g., ha-
zelnut: 0.66 mg/100 g and walnuts: 0.60 mg/100 g), dried 
fruits (banana: 0.93 mg/100 g and mango: 0.51 mg/100 g), 
and some vegetables (e.g., raw red pepper: 0.45 mg/100 g) 
contain relatively high amounts of vitamin B6 [96]. How-
ever, as pointed out previously, plant-based foods show 
sometimes high amounts of PNG [24]. For instance, high 
levels of PNG were noticed in frozen cauliflower/broccoli, 
cooked soy beans, raisins, fresh orange juice, and carrots 
with around two-thirds of the total vitamin B6 content 
[24]. In contrast, the PNG proportion in walnuts, whole-
wheat flour, bananas, and raw cauliflower is expected to 
be below 20% [24]. In a mixed diet, PNG usually accounts 
for approximately 15% of the total vitamin B6 amount 
[26]. Thus, a mixed diet can provide adequate amounts of 
vitamin B6 under the assumption of a bioavailability of 
75%. The bioavailability was taken into account by the 
D-A-CH nutrition societies when setting the reference 
values. To achieve adequate vitamin B6 supply, the daily 
intake of whole-grain products, vegetables, and fruits in-
cluding a portion of nuts is recommended. Intake of fish 
once to twice a week and a low amount of meat can also 
contribute to cover the vitamin B6 requirement.
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